Although mitogen-activated protein kinase (MAPK) pathways feature prominently in many cancers (Kolch et al., 2015), we propose that the impact of RAF-MEK-ERK signaling on FLC is complex and atypical. This evidence concerns the gene WNK2 and cancer.